Editas Medicine EDIT Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$3.6MBeat by $1.8M
EPS-$0.63Miss by $0.22
Revenue estimate$1.8M
EPS estimate-$0.41
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$2.8M
EPS estimate-$0.30
Versus estimates
Revenue
Diluted EPS
Ask the moment Editas Medicine reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Editas Medicine report Q2 2025 earnings?
- Editas Medicine (EDIT) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Editas Medicine's Q2 2025 revenue and EPS?
- Editas Medicine reported revenue of $3.6M and eps of $-0.63 for Q2 2025.
- Did Editas Medicine beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $1.8M by $1.8M. EPS missed the consensus estimate of $-0.41 by $0.22.
- How did Editas Medicine's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 597.5% from $513.0K a year earlier and eps grew 23.2% from $-0.82.
- Where can I find Editas Medicine's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001650664-25-000125) directly on SEC EDGAR. The filing index links above go to sec.gov.